Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | XIAP | P98170 | 1/20 | 0.64 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.64 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.62 |
| ▸ | ERAP1 | Q9NZ08 | 4/20 | 0.56 |
| ▸ | ANPEP | P15144 | 3/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.56 |
| ▸ | KIF11 | P52732 | 4/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.55 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.55 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.53 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.53 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.53 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.53 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.53 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.53 |
| ▸ | LAP3 | P28838 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homophenylalanine SCHEMBL44311 | 1.00 | ALPI (0.64) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL44312 | 1.00 | ALPI (0.64) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL1078733 | 1.00 | ALPI (0.64) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL28287974 | 0.98 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL28594537 | 0.98 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL1245414 | 0.98 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL1026468 | 0.98 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL2305748 | 0.98 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL28286602 | 0.98 | ALPI (0.62) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Homophenylalanine SCHEMBL1318113 | 0.93 | ALPI (0.56) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1434 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707612-A | Preparation method of gamma-deuterated amino acid ester | 浙大宁波理工学院 | 2025-03-28 | — | — | CN | claimed |
| US-20240376044-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2024-11-14 | — | — | US | claimed |
| US-20240343678-A1 | METHOD FOR SYNTHESIZING 5,8-DIAMINO-3,4-DIHYDRO-2H-1-NAPHTHALENONE AND INTERMEDIATE COMPOUND USED THEREIN | JIANGSU MABWELL HEALTH PHARMACEUTICAL R&D CO., LTD. (CN) | 2024-10-17 | — | — | US | claimed |
| WO-2024148312-A1 | COMPOSITIONS, SYSTEMS, AND METHODS FOR AMINO ACID SYNTHESIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-11 | — | — | WO | claimed |
| EP-4389732-A1 | METHOD FOR SYNTHESIZING 5,8-DIAMINO-3,4-DIHYDRO-2H-1-NAPHTHALENONE AND INTERMEDIATE COMPOUND USED THEREIN | Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. (CN) | 2024-06-26 | — | — | EP | claimed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | claimed |
| EP-4136102-A1 | LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE | I2O Therapeutics, Inc. (US) | 2023-02-22 | — | — | EP | claimed |
| CN-115703712-A | Process for the synthesis of 5,8-diamino-3,4-dihydro-2H-1-naphthalenone and intermediate compounds useful therein | 江苏迈威康新药研发有限公司 | 2023-02-17 | — | — | CN | claimed |
| WO-2021212023-A1 | LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE | INTARCIA THERAPEUTICS, INC. (US) | 2021-10-21 | — | — | WO | claimed |
| EP-3208279-B1 | MINI-HEPCIDIN PEPTIDES AND METHODS OF USING THEREOF | UNIV CALIFORNIA (US) | 2021-04-21 | — | — | EP | claimed |
| WO-1996041638-A1 | CALPAIN INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SANOFI WINTHROP, INC. (US) | 1996-12-27 | — | — | WO | claimed |
| WO-1996028467-A1 | BICYCLIC TACHYKININS ANTAGONISTS, PREPARATION THEREOF AND THEIR USE IN PHARMACEUTICAL COMPOSITION | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1996-09-19 | — | — | WO | claimed |
| US-5512548-A | CHOLESTERYL ESTER TRANSFER PROTEIN | SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1996-04-30 | — | — | US | claimed |
| EP-0672678-A1 | Azapeptide derivative | FUJIREBIO Inc. (JP) | 1995-09-20 | — | — | EP | claimed |
| EP-0636146-A1 | TACHYKININ ANTAGONIST TRICYCLIC COMPOUNDS, PREPARATION OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS. | MENARINI FARMA IND (IT) | 1995-02-01 | — | — | EP | claimed |
| US-5316943-A | For amino acids | NUTRASWEET COMPANY, THE | 1994-05-31 | — | — | US | claimed |
| WO-1993021227-A1 | TACHYKININ ANTAGONIST TRICYCLIC COMPOUNDS, PREPARATION OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1993-10-28 | — | — | WO | claimed |
| EP-0135846-B1 | PRODUCTION OF L-AMINO ACIDS BY TRANSAMINATION | GENETICS INSTITUTE, INC. (US) | 1990-08-16 | — | — | EP | claimed |
| US-4525454-A | REACTING 2-KETOACID AND L-ASPARTIC ACID IN PRESENCE OF TRANSAMINASE ENZYME | GENETICS INSTITUTE, INC. (US) | 1985-06-25 | — | — | US | claimed |
| EP-0135846-A2 | Production of L-amino acids by transamination | GENETICS INSTITUTE, INC. (US) | 1985-04-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240376044-A1 | METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE | DDC, AADAT, TYR | ALPI 1948/4885PKM 1261/4885PTGS1 4627/4885 |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | ALPI 3748/4885PKM 3544/4885PTGS1 3737/4885 |
| US-20240343678-A1 | METHOD FOR SYNTHESIZING 5,8-DIAMINO-3,4-DIHYDRO-2H-1-NAPHTHALENONE AND INTERMEDIATE COMPOUND USED THEREIN | CCKBR, DDC, DHPS | ALPI 1891/4885PKM 2262/4885PTGS1 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.